---
ticker: "BBH"
name: "VanEck Biotech ETF"
url: "https://etf.net/etf/BBH"
grade: "B"
score: 67
graded_at: "2026-10-12"
category: "Biotech & Genomics"
category_rank: "5 of 17"
methodology: "https://etf.net/methodology"
---

# BBH: VanEck Biotech ETF

Grade **B**, Score 67 of 100. Rank 5 of 17 in Biotech & Genomics.

Graded Oct 12, 2026.

## Grade pillars

| Pillar | Score | Category rank |
| --- | --- | --- |
| Cost | 81 | 3 of 17 |
| Mission | Not scored | — |
| Risk | 68 | 5 of 17 |
| Tradability | 66 | 5 of 17 |
| Holdings | 28 | 17 of 17 |
| Durability | 69 | 6 of 17 |

## Top holdings

The fund holds 25 positions. These are the largest 25, by weight.

| # | Ticker | Name | Weight |
| --- | --- | --- | --- |
| 1 | AMGN | Amgen Inc | 15.79% |
| 2 | GILD | Gilead Sciences Inc | 13.59% |
| 3 | VRTX | Vertex Pharmaceuticals Inc | 8.15% |
| 4 | MRNA | Moderna Inc | 7.20% |
| 5 | REGN | Regeneron Pharmaceuticals Inc | 6.51% |
| 6 | NTRA | Natera Inc | 5.27% |
| 7 | IQV | Iqvia Holdings Inc | 4.39% |
| 8 | ILMN | Illumina Inc | 4.18% |
| 9 | ARGX | Argenx Se | 4.01% |
| 10 | RVMD | Revolution Medicines Inc | 3.97% |
| 11 | GH | Guardant Health Inc | 2.87% |
| 12 | BIIB | Biogen Inc | 2.77% |
| 13 | ONC | Beone Medicines Ltd | 2.72% |
| 14 | ALNY | Alnylam Pharmaceuticals Inc | 2.59% |
| 15 | UTHR | United Therapeutics Corp | 2.31% |
| 16 | INCY | Incyte Corp | 2.10% |
| 17 | INSM | Insmed Inc | 1.89% |
| 18 | BNTX | Biontech Se | 1.59% |
| 19 | CRL | Charles River Laboratories Internationa | 1.56% |
| 20 | NBIX | Neurocrine Biosciences Inc | 1.42% |
| 21 | ICLR | Icon Plc | 1.22% |
| 22 | TECH | Bio-Techne Corp | 1.18% |
| 23 | BMRN | Biomarin Pharmaceutical Inc | 1.04% |
| 24 | TEM | Tempus Ai Inc | 0.98% |
| 25 | QGEN | Qiagen Nv | 0.98% |

Source: etf.net, https://etf.net/etf/BBH. Please cite the page URL.